Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hematologic Diseases × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 214 Breast Neoplasms 119 Neoplasms 93 Prostatic Neoplasms 33 Fatigue 29 Obesity 23 Colorectal Neoplasms 21 Lung Neoplasms 17 Colonic Neoplasms 15 Polycystic Ovary Syndrome 14 Ovarian Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphedema 11 Lymphoma 10 Head and Neck Neoplasms 10 Rectal Neoplasms 9 Hematologic Neoplasms 9 Weight Loss 8 Multiple Myeloma 8 Leukemia 8 Cardiotoxicity 8 Brain Neoplasms 8 Pancreatic Neoplasms 7 Insulin Resistance 7 Carcinoma, Non-Small-Cell Lung 7 Overweight 6 Cognitive Dysfunction 6 Sarcopenia 5 Peripheral Nervous System Diseases 5 Lymphoma, Follicular 5

Interventions

Cyclophosphamide 18 Brentuximab Vedotin 18 fludarabine 14 Rituximab 11 Melphalan 10 Lenalidomide 10 Busulfan 10 fludarabine phosphate 9 Mycophenolic Acid 9 Dexamethasone 9 pirtobrutinib 7 Whole-Body Irradiation 7 Tacrolimus 7 Bortezomib 7 dacetuzumab 6 ruxolitinib 5 Imatinib Mesylate 5 Doxorubicin 5 Bone Marrow Transplantation 5 Azacitidine 5 ponatinib 4 Vincristine 4 Prednisone 4 Mesna 4 Granulocyte Colony-Stimulating Factor 4 Etoposide 4 Blood Specimen Collection 4 nilotinib 3 lintuzumab 3 ibrutinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03886909 2023-07-11

IMPROVE-BMT

Milton S. Hershey Medical Center

Phase NA Completed

Hematologic Diseases, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡